News related to Reminyl (Galantamine) and/or conditions it is approved for
New Approach To Screen Individuals For Early Alzheimer's Disease
Source: Seniors / Aging News From Medical News Today [2008.11.19]
With millions of baby boomers entering late adulthood, the number of patients with Alzheimer's disease (AD) is expected to drastically rise over the next several decades. A team of national researchers, led by Emory University, has developed a rapid screening test to detect mild cognitive impairment (MCI) - often the earliest stage of AD. The findings are published in the online edition of Journal of Alzheimer's Disease.
Substance In Red Grapes And Wine Key To Alzheimer's Disease
Source: Nutrition / Diet News From Medical News Today [2008.11.18]
Scientists at The Feinstein Institute for Medical Research have figured out why a substance in red grapes and red wine lowers amyloid beta levels that accumulate in the brains of Alzheimer's patients. Medicines targeting amyloid beta that make up the clumps in the hallmark plaques are now in many phases of experimental testing.
Promising Hormone Treatment For Alzheimer's Disease And Stroke
Source: Endocrinology News From Medical News Today [2008.11.13]
Saint Louis University researchers have identified a novel way of getting a potential treatment for Alzheimer's disease and stroke into the brain where it can do its work. "We found a unique approach for delivering drugs to the brain," says William A. Banks, M.D., professor of geriatrics and pharmacological and physiological science at Saint Louis University. "We're turning off the guardian that's keeping the drugs out of the brain.
IU Study Finds 25% Of Family Caregivers Of Alzheimer's Disease Patients Go To ER Or Are Hospitalized
Source: Caregivers / Homecare News From Medical News Today [2008.11.11]
One quarter of all family caregivers of Alzheimer's disease patients succumb to the stress of providing care to a loved one and become hospital patients themselves, according to an Indiana University study published in the November 2008 issue of the Journal of General Internal Medicine.
Powerful New Evidence Shows Statin Drugs Reduce Risk Of Alzheimer's Disease
Source: Statins News From Medical News Today [2008.10.30]
Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD). The newly published results of a major long-term study (J Neurol NeuroSurg Psychiatry Oct. 17, 2008) now provides powerful new evidence that taking statins substantially reduces the risk of AD.
Alzheimer's Disease Could Be Prevented And Treated By Common Epilepsy Drug
Source: Epilepsy News From Medical News Today [2008.10.28]
The team led by UBC Psychiatry Prof. Weihong Song, who is also the Jack Brown and Family Professor and Chair in Alzheimer's Disease at UBC, found that if Valproic Acid (VPA) is used as a treatment in early stages of AD memory deficit is reversed. The study, published in the Journal of Experimental Medicine, reveals that VPA works by inhibiting the activity of an enzyme that produces a neurotoxic protein called beta Amyloid. In doing so, plaque formation is discontinued.
Statins Reduce Risk Of Alzheimer's Disease According To New Long-Term Prospective Study
Source: Cholesterol News From Medical News Today [2008.10.21]
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD), including for patients at risk for AD because of vascular-related risk factors or disease. An important new study has found that ongoing statin drug use was associated with a 67% reduction in the risk of AD (Current Alzheimer Research 2008; 5: 416-421).
Alzheimer's Disease: Home Safety Information
Source: MedicineNet Advance Medical Directives Specialty [2008.08.26]
Title: Alzheimer's Disease: Home Safety Information
Category: Diseases and Conditions
Created: 8/26/2008
Last Editorial Review: 8/26/2008
Alzheimer's Disease Patient Caregiver Guide
Source: MedicineNet Sleep Aids And Stimulants Specialty [2008.08.26]
Title: Alzheimer's Disease Patient Caregiver Guide
Category: Diseases and Conditions
Created: 8/26/2008
Last Editorial Review: 8/26/2008
Alzheimer's Disease: Finding Has Implications For Host Of Neurodegenerative Diseases
Source: CJD / vCJD / Mad Cow Disease News From Medical News Today [2008.05.19]
Researchers from the University of Pennsylvania School of Medicine have shown, in unprecedented detail, how a small molecule is able to selectively take apart abnormally folded protein fibers connected to Alzheimer's disease and prion diseases. The findings appeared online in the Proceedings of the National Academy of Sciences. Finding a way to dismantle misfolded proteins has implications for new treatments for a host of neurodegenerative diseases.
Alzheimer's Disease
Source: MedicineNet Pick Disease Specialty [2007.07.17]
Title: Alzheimer's Disease
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 7/17/2007
ARICEPT (Donepezil) effective for severe Alzheimer's disease
Source: The Doctors Lounge - Neurology
Donepezil reverses some aspects of cognitive deterioration seen in severe Alzheimer's disease.
Scientists Are High On Idea That Marijuana Reduces Memory Impairment
Source: Neurology / Neuroscience News From Medical News Today [2008.11.20]
The more research they do, the more evidence Ohio State University scientists find that specific elements of marijuana can be good for the aging brain by reducing inflammation there and possibly even stimulating the formation of new brain cells. The research suggests that the development of a legal drug that contains certain properties similar to those in marijuana might help prevent or delay the onset of Alzheimer's disease.
Gingko Biloba Not Effective Against Alzheimer's
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2008.11.19]
A randomized clinical trial involving over 3,000 elderly people in the US found that the popular herbal supplement Gingko biloba fared no better than placebo at preventing dementia or Alzheimer's disease. The research was the work of the Ginkgo Evaluation of Memory (GEM) Study Investigators who are based at centers throughout the US, including the University of Pittsburgh, Pennsylvania, where lead author Dr Steven T DeKosky, was working at the time of the investigation.
Forget Ginkgo Supplements for Dementia Prevention
Source: MedPage Today Neurology [2008.11.18]
CHARLOTTESVILLE, Va. (MedPage Today) -- The popular plant supplement Ginkgo biloba does not prevent cognitive decline or halt progress to Alzheimer's disease, researchers here found.
Ginkgo fails to prevent Alzheimer's in large study (AP)
Source: Y! Health News Search RSS Feed [2008.11.18]
AP - The dietary supplement ginkgo, long promoted as an aid to memory, didn't help prevent dementia and Alzheimer's disease in the longest and largest test of the extract in older Americans. "We don't think it has a future as a powerful anti-dementia drug," said Dr. Steven DeKosky of the University of Virginia School of Medicine, who led the federally funded study.
University Of Central Florida Students Use Wii And Yoga To Help Alzheimer's Patients
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2008.11.14]
University of Central Florida students are helping people with Alzheimer's disease and related disorders through an innovative program that blends traditional therapy along with games such as the Wii and yoga. Media are invited to attend a session from 10 a.m. to noon on Friday, Nov. 14, or Friday, Nov. 21, at First United Methodist Church of Winter Park, 125 N. Interlachen Ave.
Alzheimer's-Associated Changes In Mouse Brains Induced By Common Anesthetic
Source: Pain / Anesthetics News From Medical News Today [2008.11.13]
For the first time researchers have shown that a commonly used anesthetic can produce changes associated with Alzheimer's disease in the brains of living mammals, confirming previous laboratory studies. In their Annals of Neurology report, which has received early online release, a team of Massachusetts General Hospital (MGH) investigators shows how administration of the gas isoflurane can lead to generation of the toxic amyloid-beta (A-beta) protein in the brains of mice.
3-Substituted Indolones As Novel Therapeutic Compounds For Neurodegenerative Conditions
Source: Multiple Sclerosis News From Medical News Today [2008.10.29]
Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), disrupt the quality of life for patients, put a tremendous burden on family caregivers, and cost society billions of dollars annually. The most consistent risk factor for developing neurodegenerative disease is aging.
Compounds That Prevent Nerve Damage Discovered By Duke Team
Source: Huntingtons Disease News From Medical News Today [2008.09.24]
Duke University Medical Center scientists have made a significant finding that could lead to better drugs for several degenerative diseases including Huntington's disease and Alzheimer's disease. Compounds that block the activity of a specific enzyme prevented brain injury and greatly improved survival in fruit flies that had the same disease process found in Huntington's disease.
Pfizer And Medivation Agreement To Co-Develop And Market Dimebon For Alzheimer's And Huntington's Diseases Treatment
Source: Huntingtons Disease News From Medical News Today [2008.09.08]
Pfizer Inc (NYSE: PFE) and Medivation, Inc.(NASDAQ: MDVN) announced today that they have entered into an agreement to develop and commercialize Dimebon, Medivation's investigational drug for treatment of Alzheimer's disease and Huntington's disease. Dimebon currently is being evaluated in an international, confirmatory Phase III trial in patients with mild-to-moderate Alzheimer's disease (http://www.connectionstudy.
Mechanism Uncovered Of Action Of Antibiotic Able To Reduce Neuronal Cell Death In Brain
Source: Huntingtons Disease News From Medical News Today [2008.05.12]
Research Highlights: Mechanism of action of compound found to induce neurotransmitter activity in brain cells The findings may lead researchers to develop potential novel therapies to treat Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease,
|
